Cas:20870-90-0 5-bromo-1-methyl-3H-indol-2-one manufacturer & supplier

We serve Chemical Name:5-bromo-1-methyl-3H-indol-2-one CAS:20870-90-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-bromo-1-methyl-3H-indol-2-one

Chemical Name:5-bromo-1-methyl-3H-indol-2-one
CAS.NO:20870-90-0
Synonyms:5-Brom-1-methyl-indolin-2-on;5-bromo-1-methyl-1,3-dihydro-indole-2-one;5-Bromo-1-methylindolin2-one;5-bromo-1-methyl-1,3-dihydro-indol-2-one;5-bromo-1-methyl-1,3-dihydro-2H-indol-2-one;5-bromo-1-methyl-1H-indolin-2-one;5-Bromo-1-methyl-2-oxoindoline
Molecular Formula:C9H8BrNO
Molecular Weight:226.07000
HS Code:2933790090

Physical and Chemical Properties:
Melting point:132ºC
Boiling point:418.1ºC at 760mmHg
Density:1.589g/cm3
Index of Refraction:1.619
PSA:20.31000
Exact Mass:224.97900
LogP:2.03300

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Brom-1-methyl-indolin-2-on chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-1-methyl-2-oxoindoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-1-methyl-1,3-dihydro-indol-2-one Use and application,5-bromo-1-methyl-1,3-dihydro-indole-2-one technical grade,usp/ep/jp grade.


Related News: The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. 5-bromo-1-methyl-3H-indol-2-one manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 5-bromo-1-methyl-3H-indol-2-one supplier European companies are the main suppliers of specialty APIs, but due to environmental and cost pressures, APIs have begun to shift to the Asian market. 5-bromo-1-methyl-3H-indol-2-one vendor A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. 5-bromo-1-methyl-3H-indol-2-one factory The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward.